Ginkgo biloba for Prevention of Acute Mountain Sickness: Does It Work?

被引:13
作者
van Patot, Martha C. Tissot [1 ,2 ]
Keyes, Linda E. [2 ]
Leadbetter, Guy, III [3 ]
Hackett, Peter H. [2 ,4 ]
机构
[1] Univ Colorado Denver, Dept Anesthesiol, Aurora, CO 80045 USA
[2] Univ Colorado, Dept Surg, Div Emergency Med, Altitude Res Ctr, Denver, CO USA
[3] Mesa State Coll, Dept Exercise Physiol, Grand Junction, CO USA
[4] Inst Altitude Med, Telluride, CO USA
关键词
Gingko biloba; hypoxia; acute mountain sickness; oxidative stress; herbal medicine; PLATELET-ACTIVATING-FACTOR; EXPERIMENTALLY DIABETIC-RATS; EXTRACT EGB 761; IN-VIVO; OXIDATIVE STRESS; GINGKO-BILOBA; HIGH-ALTITUDE; ZINGIBER-OFFICINALE; ENZYME-ACTIVITIES; NITRIC-OXIDE;
D O I
10.1089/ham.2008.1085
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
Tissot van Patot, Martha, Linda E. Keyes, Guy Leadbetter III, and Peter H. Hackett. Ginkgo biloba for the prevention of acute mountain sickness: does it work? High Alt. Med. Biol. 10:00-00, 2009.-We review the current literature regarding the prophylactic use of Ginkgo biloba extract (GBE) in acute mountain sickness (AMS). We compare studies with regard to GBE dose, composition, study design, altitude reached, ascent rate, exercise, and risk of AMS. We then review what is known about the active components of GBE and their biological effects and apply this knowledge to interpret the results of AMS prevention trials. Overall, the literature suggests that due to the complexity of GBE the standardization of the product is inadequate, which likely explains the disparate clinical results. The variability in commercially available GBE products makes it impossible to determine whether GBE is truly effective for preventing or ameliorating AMS. However, investigating the roles of specific active components of GBE in the prevention of AMS could yield rewards both clinically and in our understanding of the pathophysiology of AMS.
引用
收藏
页码:33 / 43
页数:11
相关论文
共 164 条
[41]  
DORMAN DC, 1992, AM J VET RES, V53, P138
[42]  
Droy-Lefaix M T, 1992, Lens Eye Toxic Res, V9, P521
[43]  
Dubey A-K, 2004, Kathmandu Univ Med J (KUMJ), V2, P225
[44]   Efficacy and harm of pharmacological prevention of acute mountain sickness:: quantitative systematic review [J].
Dumont, L ;
Mardirosoff, C ;
Tramèr, MR .
BRITISH MEDICAL JOURNAL, 2000, 321 (7256) :267-272
[45]  
Eckert A, 2003, PHARMACOPSYCHIATRY, V36, pS15
[46]   Effects of Ginkgo biloba on plasma oxidant injury induced by bleomycin in rats [J].
Erdogan, H ;
Fadillioglu, E ;
Kotuk, M ;
Iraz, M ;
Tasdemir, S ;
Oztas, Y ;
Yildirim, Z .
TOXICOLOGY AND INDUSTRIAL HEALTH, 2006, 22 (01) :47-52
[47]   Therapeutic efficacy of EGb761 (Gingko biloba extract) in a transgenic mouse model of amyotrophic lateral sclerosis [J].
Ferrante, RJ ;
Klein, AM ;
Dedeoglu, A ;
Beal, MF .
JOURNAL OF MOLECULAR NEUROSCIENCE, 2001, 17 (01) :89-96
[48]   Protective effects of Ginkgo biloba extract EGb 761 on myocardium of experimentally diabetic rats - I: Ultrastructural and biochemical investigation on cardiomyocytes [J].
Fitzl, G ;
Martin, R ;
Dettmer, D ;
Hermsdorf, V ;
Drews, H ;
Welt, K .
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY, 1999, 51 (03) :189-198
[49]  
Fitzl G, 2001, EXP TOXICOL PATHOL, V52, P557, DOI 10.1016/S0940-2993(01)80017-8
[50]   Effects of herbal extracts on the function of human organic anion-transporting polypeptide OATP-B [J].
Fuchikami, H ;
Satoh, H ;
Tsujimoto, M ;
Ohdo, S ;
Ohtani, H ;
Sawada, Y .
DRUG METABOLISM AND DISPOSITION, 2006, 34 (04) :577-582